The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

ResMed Inc

NYSE: RMD
Last

(U.S.) $70.91

Today's change+0.17 +0.24%
Updated April 25 3:48 PM EDT. Delayed by at least 15 minutes.
 

ResMed Inc

NYSE: RMD
Last

(U.S.) $70.91

Today's change+0.17 +0.24%
Updated April 25 3:48 PM EDT. Delayed by at least 15 minutes.

ResMed Inc up (U.S.)$0.17

ResMed Inc closed up Tuesday by (U.S.)$0.17 or 0.24% to (U.S.)$70.91. Over the last five days, shares have gained 3.29% and are currently 3.47% off of the 52-week high. Shares have performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $71.01
  • Previous close(U.S.) $70.74
  • High(U.S.) $71.24
  • Low(U.S.) $70.78
  • Bid / Ask(U.S.) $70.91 / (U.S.) $70.92
  • YTD % change+14.28%
  • Volume696,221
  • Average volume (10-day)611,953
  • Average volume (1-month)634,589
  • Average volume (3-month)763,767
  • 52-week range(U.S.) $55.43 to (U.S.) $73.46
  • Beta0.89
  • Trailing P/E30.07×
  • P/E 1 year forward25.16×
  • Forward PEG2.39×
  • Indicated annual dividend(U.S.) $1.32
  • Dividend yield1.86%
  • Trailing EPS(U.S.) $2.36
Updated April 25 3:48 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.28%Sector:HealthcareIndustry:Advanced Medical Equipment

Latest Company News

View more News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue530465519454
Total other revenue--------
Total revenue530465519454
Gross profit309269301260
Total cost of revenue221196217194
Total operating expense434371400350
Selling / general / administrative139129136123
Research & development38343428
Depreciation / amortization1212135
Interest expense (income), net operating--------
Unusual expense (income)23--00
Other operating expenses, total--------
Operating income9794119104
Interest income (expense), net non-operating-----11--
Gain (loss) on sale of assets--------
Other--------
Income before tax9693117109
Income after tax77769388
Income tax, total19172421
Net income77769388
Total adjustments to net income--------
Net income before extra. items77769388
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items77769388
Inc. avail. to common incl. extra. items77769388
Diluted net income77769388
Dilution adjustment--00--
Diluted weighted average shares142142142141
Diluted EPS excluding extraordinary itemsvalue per share0.540.540.660.63
Dividends per sharevalue per share0.330.330.300.30
Diluted normalized EPSvalue per share0.670.540.660.63